IRIS UniCatt

Bassi, Pierfrancesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.835
NA - Nord America 7.852
AS - Asia 2.940
SA - Sud America 502
AF - Africa 87
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 17
Totale 32.252
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 12.769
US - Stati Uniti d'America 7.703
DE - Germania 2.622
SE - Svezia 1.473
CN - Cina 1.041
SG - Singapore 988
FR - Francia 761
UA - Ucraina 738
NL - Olanda 674
BR - Brasile 438
GB - Regno Unito 371
IE - Irlanda 350
PL - Polonia 304
IN - India 293
ID - Indonesia 217
RU - Federazione Russa 180
FI - Finlandia 176
CA - Canada 101
CH - Svizzera 92
BE - Belgio 88
TR - Turchia 83
JP - Giappone 71
ES - Italia 48
CI - Costa d'Avorio 37
HK - Hong Kong 34
VN - Vietnam 33
AT - Austria 31
KR - Corea 31
MA - Marocco 24
RO - Romania 24
IR - Iran 23
AR - Argentina 21
AL - Albania 17
MX - Messico 16
IQ - Iraq 14
AZ - Azerbaigian 13
CZ - Repubblica Ceca 13
AU - Australia 12
BZ - Belize 12
EU - Europa 12
LT - Lituania 12
BD - Bangladesh 11
TW - Taiwan 11
CO - Colombia 10
EC - Ecuador 10
GR - Grecia 10
HU - Ungheria 10
PK - Pakistan 10
PT - Portogallo 10
ZA - Sudafrica 8
AE - Emirati Arabi Uniti 7
DO - Repubblica Dominicana 7
IL - Israele 7
LK - Sri Lanka 7
MY - Malesia 7
PA - Panama 7
PE - Perù 7
RS - Serbia 7
BO - Bolivia 6
LV - Lettonia 6
PH - Filippine 6
TH - Thailandia 6
UZ - Uzbekistan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BG - Bulgaria 5
EG - Egitto 5
KG - Kirghizistan 5
SM - San Marino 5
CL - Cile 4
IS - Islanda 4
LU - Lussemburgo 4
MD - Moldavia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
TN - Tunisia 4
VE - Venezuela 4
AM - Armenia 3
BY - Bielorussia 3
DK - Danimarca 3
HR - Croazia 3
SK - Slovacchia (Repubblica Slovacca) 3
A1 - Anonimo 2
CR - Costa Rica 2
CV - Capo Verde 2
DZ - Algeria 2
EE - Estonia 2
HN - Honduras 2
JO - Giordania 2
MT - Malta 2
NP - Nepal 2
SI - Slovenia 2
UG - Uganda 2
BA - Bosnia-Erzegovina 1
CM - Camerun 1
CY - Cipro 1
GE - Georgia 1
GY - Guiana 1
IM - Isola di Man 1
KE - Kenya 1
KH - Cambogia 1
Totale 32.238
Salva come PNG Salva come JPEG
Città #
Chandler 1.621
Milan 1.317
Rome 1.171
Ashburn 653
Singapore 602
Jacksonville 424
Naples 356
Dublin 338
San Mateo 331
Ann Arbor 311
Wilmington 244
Nanjing 242
Florence 236
Turin 229
Jakarta 210
Warsaw 190
Bologna 189
Los Angeles 177
Palermo 156
Dearborn 153
Houston 147
Woodbridge 144
New York 141
Bari 140
Munich 132
Bremen 129
Nanchang 125
Nürnberg 122
Catania 116
Lawrence 114
Genoa 111
Boston 109
Fairfield 107
Verona 107
Moscow 96
Cattolica 90
Beijing 89
Marseille 89
Redwood City 87
Kraków 83
Princeton 79
The Dalles 79
Seattle 77
Brussels 74
Brescia 69
Frankfurt am Main 69
Padova 66
Chicago 63
Lancaster 55
Mountain View 55
Venice 55
Falls Church 51
Ottawa 50
Parma 46
Kunming 45
São Paulo 45
Cagliari 44
Izmir 43
Redmond 42
Taranto 42
Helsinki 41
Hyderabad 41
Messina 41
Bergamo 39
Perugia 39
Abidjan 37
Boardman 37
Tianjin 36
Cambridge 35
Pescara 35
Reggio Emilia 34
Salerno 34
University Park 34
Hebei 33
Düsseldorf 32
Livorno 32
San Jose 32
London 31
Norwalk 31
Toronto 31
Hefei 30
Jiaxing 30
Hong Kong 29
Paris 29
Shenyang 29
Augusta 28
Hangzhou 28
Kadoma 28
Trieste 28
Changsha 27
Modena 27
Novara 26
Lucca 24
Seoul 24
Amsterdam 23
Rimini 23
Guangzhou 22
Lauterbourg 21
Shanghai 21
Monza 20
Totale 13.799
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 10.042
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.119
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 855
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 798
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 492
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 367
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 349
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 311
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 274
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 267
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 265
Pros-IT CNR: an Italian prostate cancer monitoring project 236
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 206
(99m)Tc-MAG3 diuretic renography in diagnosis of obstructive nephropathy in adults: a comparison between F-15 and a new procedure F+10(sp) in seated position 189
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 189
E-CADHERIN AND IL-6 SERUM LEVELS IN PATIENTS AFFECTED BY PROSTATE CANCER BEFORE AND AFTER PROSTATECTOMY 185
Le infezioni delle vie urinarie 184
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 182
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 177
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy 156
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 155
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 150
Evidenze microbiologiche in un singolo centro urologico 144
Urological complications following inguinal hernioplasty 144
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 144
The occult urothelial cancer 142
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 140
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence 139
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 134
Male infertility: non-surgical therapy 134
Metabolic reprogramming by malat1 depletion in prostate cancer 134
[Urinary peptides and calcium oxalate nephrolithiasis, a combined approach: MALDI-TOF mass spectrometry and MicroBCA Protein Assay] 132
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 131
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review 131
Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy 130
Human factors in surgery: from Three Mile Island to the operating room 129
Extracorporeal shockwave lithotripsy in pediatrics 128
Le complicanze nella chirurgia urologica 128
[Overactive bladder syndrome: the social and economic perspective] 127
Imaging in prostate cancer diagnosis: present role and future perspectives 126
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 126
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 126
Chirurgia robotica per tutti 126
KV7 channels in the human detrusor: channel modulator effects and gene and protein expression 126
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 125
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 123
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 123
(99m)Tc-Mag3 Diuretic Renography In Assessment Of Obstructive Uropathy. The New Test F+10sp: A Step Ahead In The Differential Diagnosis 122
Hot topics in urological health economics. A mini review 121
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 121
Antibiotic prophylaxis in urology 121
Bladder and prostate metastasis from small cell lung cancer: a rare entity 121
L' era del PCA3: risultati preliminari di uno studio pragmatico monocentrico 120
Brachytherapy in men with prostate cancer: update on indications and outcomes 120
Positive surgical margins in nephron sparing surgery for renal cell carcinoma 120
[Foreign bodies in urinary bladder: a clinical case] 118
Advanced bladder cancer: New agents and new approaches. A review 118
Imaging in prostate cancer staging: present role e future perspectives 117
NBI: results review 115
Imaging of renal cell carcinoma: state of the art and recent advances 114
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up 114
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 113
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 113
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 113
Germ Cell Neoplasia in situ (GCNIS) in Testis-Sparing Surgery (TSS) for Small Testicular Masses (STMs) 112
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 111
Size of Bladder Cancers: Correlation among Different Types of Measurement 110
Behavioural profile and human adaptation of survivors after radical cystectomy and ileal conduit 110
Advanced bladder cancer: New agents and new approaches. A review 109
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 109
Neutrophil gelatinase-associated lipocalin (NGAL) value changes before and after shock wave lithotripsy 108
Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB) 106
The Clinical Use of Statistical Permutation Test Methodology: A Tool for Identifying Predictive Variables of Outcome 106
Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients 106
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "bCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes 106
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 105
Inhibition of prostate efferent neurotransmission by amikacin 104
Surgery for male urinary incontinence: where are we now and what is in the pipeline? 104
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 103
Bradeion (SEPT4) as a Urinary Marker of Transitional Cell Bladder Cancer: A Real-Time Polymerase Chain Reaction Study of Gene Expression 103
Imaging in prostate cancer staging: present role and future perspectives 101
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 101
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 99
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 99
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 98
Therapeutic strategies in penile cancer: state of the art 98
[Innovative treatments of non muscle invasive bladder cancer] 98
Mitomycin C: new strategies to improve efficacy of a well-known therapy 98
The occult urothelial cancer 98
Test F+10 SP: un nuovo metodo angioscintigrafico per la diagnosi dell'uropatia ostruttiva 97
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 97
Second-line intravesical therapy. What is the present role of device-assisted therapy? 96
Current status of robotic urologic surgery in Italy 94
H19-Dependent Transcriptional Regulation of beta 3 and beta 4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer 93
Circumcision: history, religion and law 92
Imaging of renal cell carcinoma: state of the art and recent advances 92
Local relapse of prostate cancer after primary definitive treatment: the management 92
Is extracorporeal shock wave lithotripsy in pediatrics a safe procedure? 91
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 91
HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response 90
Totale 26.068
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.885
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.885
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020216 0 0 0 0 0 0 0 0 0 0 0 216
2020/20212.008 84 198 114 200 267 135 195 76 221 108 305 105
2021/20222.265 216 147 77 181 186 112 79 295 138 158 303 373
2022/20235.971 684 634 415 773 341 639 270 476 636 280 479 344
2023/20246.883 383 809 433 550 476 598 528 628 449 613 641 775
2024/20258.813 640 753 880 714 952 638 643 722 1.099 743 989 40
Totale 32.542